The drain on the battery is about 300 mA as measured on a D.C. meter. This should allow several hours' operation, and as the buzzer is actually in operation for only about 30 seconds per session, battery wastage is no great problem.
Summary
A simple apparatus which can deliver a painful electric shock to the subject for aversion therapy is described. It has advantages over nausea-producing drugs, particularly in allowing the patient to treat himself even at home. The use of the apparatus is illustrated by cases of fetishism, obsessional ruminations, smoking, writer's cramp, and alcoholism. Technical details are given of the components and their assembly which requires only the most rudimentary knowledge of electricity. Soon after the introduction of suxamethonium ("anectine," " brevidil M," " scoline," etc.) into clinical anaesthesia in 1951, the occasional occurrence of prolonged paralysis, even in the absence of excessive dosage, was reported (Love, 1952; Gould, 1952; Harper, 1952 (Kalow and Genest, 1957; Kalow and Staron, 1957) has facilitated accurate diagnosis in the cases where the apnoea is due to the presence of an atypical form of pseudocholinesterase.
Types of Neuromuscular Block
Prolonged apnoea after suxamethonium may be due to central respiratory depression, to peripheral neuromuscular block, or to a combination of both. The peripheral neuromuscular block may be attributed to one or more of the following four mechanisms:
1. Succinylmonocholine and Choline Block.-Suxamethonium is normally broken down to succinylmonocholine and choline. The succinylmonocholine in turn is broken down to succinic acid and choline. The monocholine and to a less extent choline have each a weak depolarizing action. However, effective concentrations of these substances are unlikely to accumulate unless massive doses of suxamethonium have been given-for example, 1.5 to 2 g. (Wylie and Churchill-Davidson, 1960). 2. Dual Block.-After an intravenous injection of suxamethonium, certain individuals develop a non-depolarizing block at the motor end-plate following the original depolarizing block. This is usually seen after multiple doses of suxamethonium, but occasionally it appears even after a single dose. Patients with myasthenia gravis are particularly prone to develop this type of response (Churchill-Davidson, 1955) . This type of block is temporarily improved by edrophonium, and is reversed by neostigmine.
3. Deficiency of Normal Type of Pseudocholinesterase.-As pseudocholinesterase is normally responsible for the rapid destruction of suxamethonium, any reduction in its activity will prolong the effect of the drug. The production of this enzyme is depressed by certain pathological conditions. These include liver disease, severe malnutrition, and hypoproteinaemia other than that due to renal disease. Its action is inhibited by organophosphorus compounds such as are used in nerve gases and * From the Departments of Anacsthetics and Biochemintry, Royal Infirmary.
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insecticides. Complete absence of pseudocholinesterase has been reported (Hart and Mitchell, 1962 by, Lehmann and Liddell (1962) . The typical and atypical forms of pseudocholinesterase differ in their activity in the presence of dibucaine. The normal enzyme is inhibited to a much greater extent than the atypical form, which is virtually unaffected. This fact has been used by Kalow and Genest (1957) and Kalow and Staron (1957) 
Case 1
A 51-year-old married woman was anaesthetized for treatment of bilateral varicose veins. Premedication was with pethidine 100 mg. and atropine 0.6 mg. one hour before operation. Induction of anaesthesia was with thiopentone 250 mg. followed by suxamethonium 50 mg. to facilitate endotracheal intubation. It was intended to allow spontaneous respiration with nitrous oxide, oxygen, and 1 % halothane, and the patient was ventilated with this mixture. However, when no muscle tone or respiratory effort was present after 10 minutes the halothane was switched off and ventilation continued with nitrous oxide 3.5 1./min. and oxygen 1.5 1./min., using the Coxeter-Mushin absorber with fresh soda-lime.
An attempt was made to restart spontaneous respiration by adding 5 % carbon dioxide to the mixture for 30 seconds with the absorber out of circuit. This had no effect, nor did the intravenous injection of 2 ml. of nikethamide. Controlled ventilation was therefore continued as before until spontaneous respiration returned one hour later. The patient made an uneventful recovery.
Her dibucaine No. was later found to be 49%. The patient, her mother, daughter, and four of her siblings are heterozygous. There are no abnormal homozygotes (Fig. 1) .
B ymm MEDICAL JOURN.AL tube. Intermittent positive-pressure ventilation was then started, using nitrous oxide 3.5 I./min. and oxygen 1.5 I./min. through fresh soda-lime in a Coxeter-Mushin absorber. Ventilation was continued as described until the end of the operation one hour later, the patient being apnoeic throughout although no further suxamethonium had been required. At this time 5% carbon dioxide was given for 30 seconds with the absorber out of circuit, but the patient remained apnoeic. Ventilation was continued for a further one and three-quarters hours before respiration recommenced spontaneously two and three-quarters hours after the induction dose of suxamethonium.
The patient's dibucaine No. was 24%, and the baby, which cried immediately at birth, had a dibucaine No. of 71 % at the age of 5 months.
The patient and her younger sister are both homozygous for the atypical enzyme. Both her parents, another sister, and her baby daughter are heterozygous (Fig. 2) (Fig. 4) . Premedication was with heptabarbitone (" medomin ") 400 mg. given orally five hours before operation and atropine 0.6 mg. given intravenously immediately before induction. (The anaesthetist was Dr. G. B. Hendry.) Anaesthesia was induced with thiopentone 250 mg. and was maintained with nitrous oxide, oxygen, and halothane 1 %. Because she was too "tight " for adequate pelvic examination, suxamethonium 30 mg. was injected intravenously.
Fifteen minutes later, as she was still apnoeic, carbon dioxide 10% was added to the nitrous-oxide/oxygen mixture for 12 " breaths." This had no effect, and after a suitable interval nikethamide 6 ml. apnoea does not justify anaesthetists in abandoning the use of suxamethonium; similarly, the occurrence is so uncommon as to make it impracticable to test every patient prior to operation. We feel, however, that once an untoward reaction has been noted in one patient it should be possible to avoid a similar episode in the same patient or his relatives at a later date. In our own series of seven patients, one (Case 5) did not appreciate the necessity of informing the anaesthetist of her previous difficulty, and since the original case sheet was not available at the time of her recent operation no trouble was anticipated. This incident could have been avoided. One patient (Case 2) has a sister who had an apnoea following suxamethonium seven years previously. If she and her family could have been investigated then, the patient's apnoea would have been avoided. Case 3 has been fully investigated since his apnoea. He is on a waiting-list for tonsillectomy, and we hope that this complication will be avoided then. In Case 4 the fact that the parents and general practitioner were informed of the prolonged apnoea of the patient's sister alerted us to the -possibility of this problem also arising with her brother. 40 and 75%-and both had periods of prolonged apnoea. It has been suggested that apnoea occurring in such patients is due to heterozygosity of the atypical pseudocholinesterase with a third variant of the enzyme, which also fails to break down suxamethonium (Lehmann et al., 1963) . This third variant was described by Harris and Whittaker (1961) 
Conclusions and Summary
A series of seven cases possessing an atypical form of pseudocholinesterase is reported. Six of these cases presented as a prolonged response to suxame-thonium. The familial incidence is demonstrated.
Of the 33 persons tested, eight, including five of the seven original patients, were homozygous for the abnormal gene and 19 were heterozygous, of whom two were sensitive. The population at risk is therefore greater than the actual incidence of apnoea.
The procedure recommended by Lehmann and Ryan (1956) following the discovery of a sensitive individual is quoted.
The importance of warning all patients, their relatives, and their general practitioners of their abnormality is re-emphasized, and the necessity for clearly marking hospital case-sheets is stressed.
